# In vitro culture of human-infecting Encephalitozoon spp. for genome sequencing with minimal host contaminant

## TL;DR

This paper describes a new method to grow and purify Encephalitozoon microsporidia in the lab, enabling high-quality genome sequencing with minimal contamination from host DNA.

## Contribution

An optimized, reproducible protocol for culturing Encephalitozoon spp. with high genomic yield and minimal host DNA contamination is introduced.

## Key findings

- The method produced approximately one billion spores in one month with high genomic DNA quality.
- Host DNA contamination was reduced to 3–17%, as shown by sequencing data.
- Telomere-to-telomere genome assemblies were generated for three Encephalitozoon species.

## Abstract

Microsporidia are obligate intracellular parasites infecting a wide range of hosts, including humans. They can cause severe infectious diseases if left untreated, particularly in immunocompromised individuals. The propagation of the human-infecting microsporidian species in vitro is essential for generating sufficient material for genomics studies, yet existing protocols often lack detail, accessibility, or strategies to minimize host DNA contamination. Here, we present an optimized, reproducible protocol for culturing Encephalitozoon spp. in human foreskin fibroblasts (HFF-1), designed to produce high-yield and high-quality genomic DNA with minimal host DNA for downstream sequencing experiments. In one month, our method yielded approximately one billion spores, which were purified using mechanical disruption, filtration, detergent treatment, and DNase I treatment to remove free host DNA. The reduction of host DNA was validated through PCR, and next-generation sequencing – with Illumina, PacBio and Oxford Nanopore – revealing that 83–97% of the reads mapped to microsporidian genomes. This protocol enabled the generation of the first telomere-to-telomere assemblies for E. cuniculi, E. hellem, and E. intestinalis. Our workflow provides a robust framework for producing microsporidian genomic material suitable for advanced genomics applications, with potential adaptability to other intracellular pathogens.